MOLINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 5.440
EU - Europa 2.366
AS - Asia 1.984
SA - Sud America 498
AF - Africa 181
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 10.477
Nazione #
US - Stati Uniti d'America 5.365
SG - Singapore 792
IT - Italia 563
CN - Cina 562
BR - Brasile 432
RU - Federazione Russa 344
HK - Hong Kong 266
IE - Irlanda 260
SE - Svezia 239
DE - Germania 216
UA - Ucraina 166
FR - Francia 150
VN - Vietnam 135
GB - Regno Unito 133
CI - Costa d'Avorio 98
FI - Finlandia 73
IN - India 59
DK - Danimarca 46
CA - Canada 43
NL - Olanda 43
TR - Turchia 42
MA - Marocco 36
AT - Austria 31
ZA - Sudafrica 31
AR - Argentina 29
JP - Giappone 29
MX - Messico 28
PL - Polonia 27
KR - Corea 23
BD - Bangladesh 19
BE - Belgio 18
ES - Italia 18
EC - Ecuador 12
ID - Indonesia 11
IQ - Iraq 11
GR - Grecia 8
LT - Lituania 8
UZ - Uzbekistan 7
CL - Cile 6
CZ - Repubblica Ceca 6
CO - Colombia 5
EG - Egitto 5
PE - Perù 5
TH - Thailandia 5
DZ - Algeria 4
PY - Paraguay 4
AU - Australia 3
CH - Svizzera 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
JM - Giamaica 2
KG - Kirghizistan 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
BB - Barbados 1
EE - Estonia 1
GE - Georgia 1
LI - Liechtenstein 1
MT - Malta 1
MY - Malesia 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.477
Città #
Ashburn 746
Chandler 620
Singapore 500
Dallas 488
Des Moines 313
Hong Kong 265
Boardman 260
Dublin 251
Fairfield 232
New York 190
Jacksonville 189
Beijing 129
Los Angeles 123
Seattle 117
Wilmington 108
The Dalles 98
Abidjan 97
Houston 95
Munich 91
Woodbridge 91
Lawrence 82
Princeton 82
Moscow 76
Cambridge 72
Ann Arbor 62
San Mateo 62
Council Bluffs 59
Ancona 57
Centro 57
Hefei 54
London 45
Ho Chi Minh City 44
Chicago 43
Buffalo 40
San Diego 40
Turin 40
Turku 38
Washington 38
São Paulo 37
Pune 32
Shanghai 31
Guangzhou 29
Boydton 28
Santa Clara 27
Brooklyn 26
Johannesburg 26
Rome 26
Wuhan 25
Hanoi 24
Columbus 23
Warsaw 23
Tokyo 22
Nuremberg 21
Montreal 19
Brussels 18
Milan 18
San Francisco 17
Urbisaglia 16
Denver 15
Helsinki 15
Tolentino 15
Vienna 15
Marche 14
Atlanta 12
Chennai 11
Curitiba 11
Haiphong 11
Salt Lake City 11
Stockholm 11
Boston 10
Kazan' 10
Orem 10
Civitanova Marche 9
Elk Grove Village 9
Menlo Park 9
Poplar 9
Porto Alegre 9
Amsterdam 8
Ascoli Piceno 8
Brasília 8
Chaozhou 8
Da Nang 8
Dronten 8
Jiaxing 8
Kilburn 8
Manchester 8
Norwalk 8
Phoenix 8
Rio de Janeiro 8
Belo Horizonte 7
Falls Church 7
Frankfurt am Main 7
Mexico City 7
Perugia 7
Tashkent 7
Wuxi 7
Ankara 6
Cagliari 6
Charlotte 6
Falconara Marittima 6
Totale 6.867
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 271
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 162
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 150
Involvement of the oral cavity in psoriasis: results of a clinical study 140
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 136
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 132
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 127
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 122
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 121
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 121
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 120
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 118
Oxidative stress and alterations of paraoxonases in atopic dermatitis 118
Biologic Therapy in Psoriasis: Safety Profile 116
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 115
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 115
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 115
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 114
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 114
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 113
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 112
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 111
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 110
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 109
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 108
Review: A safety profile of dalbavancin for onand off-label utilization 108
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 104
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 102
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 102
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 102
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 101
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 100
Reticulated acanthoma with sebaceous differentiation 100
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 100
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 99
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 98
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 97
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 96
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 96
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 95
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 95
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 95
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 94
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 93
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 92
Topical application of fumaric acid esters improves appearance of nail psoriasis 92
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 91
Mycosis Fungoides-like Eruption and Infliximab 91
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 89
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 89
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 88
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 88
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 88
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 88
Relapsing acute generalized exanthematous pustolosis: a guess. 88
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 88
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 87
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 87
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 86
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 86
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 85
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 84
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 84
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 83
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 82
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 82
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 81
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 80
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 80
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 80
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 79
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 78
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 77
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 77
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 74
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 73
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 73
Phototherapy in Dermatology 73
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 73
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 72
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 72
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 72
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 71
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 71
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 70
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 69
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 69
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 69
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 69
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 68
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 67
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. 67
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 67
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 67
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 67
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 66
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 65
Biological treatments for pediatric psoriasis: state of the art and future perspectives 64
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 64
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 63
Totale 9.412
Categoria #
all - tutte 61.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 0 84 112 47 67 92 155 59
2021/2022692 16 100 27 12 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20263.041 561 409 548 694 739 90 0 0 0 0 0 0
Totale 10.832